http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012031928-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a568c9e456ffc5ef700194a099c71f3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cce73c6de69ba0d86da281c33f67cb31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5575994aa6036c28cebaa8eff5cb1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93bcd05be2677970548a628a5be92f42 |
| publicationDate | 2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112012031928-B1 |
| titleOfInvention | Pharmaceutical compositions which include paracetamol and process for preparing the same |
| abstract | pharmaceutical compositions which include paracetamol and process for preparing the same. provided herein are injectable compositions which have a high concentration of acetaminophen or pharmaceutically acceptable salts thereof, where the concentration of acetaminophen or a pharmaceutically acceptable salt of acetaminophen is (greater than) 150mg/ml in a judiciously adapted solvent system, which includes glycofurol, ethanol, water or a solvent system which includes glycofurol, ethanol, polyethylene glycol, water. the viscosity of the injectables mentioned is (less than) 28 cps (centipoises). the process for preparing the aforementioned injectables is also provided. injectables can be administered via the intramuscular route, intravenous route or as an intravenous infusion after being diluted in one of the commonly used intravenous fluids, amoebicidal, antifungal and antibacterial drug infusion solutions and together with anxiolytics (midazolam injection) or narcotic analgesics ( fentanyl citrate injection) because they remain stable, clear and transparent for at least 6 hours after dilution. |
| priorityDate | 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.